LENZELTA® is a new vaccine significantly reducing the incidence and severity of clinical mastitis in vaccinated cows and heifers1. Administration is simple with two doses during the dry-off period.

Humans have occupational diseases.For computer work, it's stiff shoulders or eye strain.For standing work, it's the lower ...

TRIESENBERG, Liechtenstein--(BUSINESS WIRE)--Amicogen, a leading biotech company specializing in industrial enzyme production and drug development, has partnered with Lysando, an innovative biotech ...

Mastitis remains the most prevalent and costly disease affecting dairy herds worldwide, characterised by inflammation of the mammary gland most often linked to bacterial infection. Its impacts extend ...

Bovine mastitis, which affects cows, leads to reduced milk production and can be fatal if left untreated. The USDA National Animal Health Monitoring System has reported cases in 99.7% of all dairy ...

A fatty acid already prized in nutrition circles may have found its most compelling role yet: shielding the mammary gland ...

However, farms must put a strong focus on watching out for heifer mastitis in the back-end of the year, as it can affect the ...

The dairy industry has been plagued by a persistent global problem for decades - bacterial infection of cow udders that significantly reduces milk production. The condition, known as bovine mastitis, ...

A new study identified biting flies as reservoirs of bacteria that cause bovine mastitis on dairy farms. Bovine mastitis, which affects cows, leads to reduced milk production and can be fatal if left ...

Brazilian startup WiMilk has developed a system that uses artificial intelligence to identify behavioural changes associated with bovine mastitis. The team estimates that a farm with 150 cows could ...

That final recording can flag newly infected, high-cell-count cows that may need targeted treatment at drying off.

LENZELTA ® is a new vaccine significantly reducing the incidence and severity of clinical mastitis in vaccinated cows and heifers Boehringer Ingelheim has introduced LENZELTA®, a new vaccine designed ...